JP2023536730A5 - - Google Patents

Info

Publication number
JP2023536730A5
JP2023536730A5 JP2023507241A JP2023507241A JP2023536730A5 JP 2023536730 A5 JP2023536730 A5 JP 2023536730A5 JP 2023507241 A JP2023507241 A JP 2023507241A JP 2023507241 A JP2023507241 A JP 2023507241A JP 2023536730 A5 JP2023536730 A5 JP 2023536730A5
Authority
JP
Japan
Prior art keywords
prefilled cartridge
polymer
pharmaceutical formulation
liquid pharmaceutical
disposable polymer
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2023507241A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023536730A (ja
JP7844438B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/044723 external-priority patent/WO2022031959A1/en
Publication of JP2023536730A publication Critical patent/JP2023536730A/ja
Publication of JP2023536730A5 publication Critical patent/JP2023536730A5/ja
Application granted granted Critical
Publication of JP7844438B2 publication Critical patent/JP7844438B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2023507241A 2020-08-05 2021-08-05 フロセミドを使用した治療方法 Active JP7844438B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063061518P 2020-08-05 2020-08-05
US63/061,518 2020-08-05
PCT/US2021/044723 WO2022031959A1 (en) 2020-08-05 2021-08-05 Methods of treatment using furosemide

Publications (3)

Publication Number Publication Date
JP2023536730A JP2023536730A (ja) 2023-08-29
JP2023536730A5 true JP2023536730A5 (https=) 2024-08-14
JP7844438B2 JP7844438B2 (ja) 2026-04-13

Family

ID=77774970

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023507241A Active JP7844438B2 (ja) 2020-08-05 2021-08-05 フロセミドを使用した治療方法

Country Status (9)

Country Link
US (1) US20230270759A1 (https=)
EP (2) EP4192473B1 (https=)
JP (1) JP7844438B2 (https=)
CN (1) CN116322704A (https=)
AU (1) AU2021320308A1 (https=)
CA (1) CA3190585A1 (https=)
IL (1) IL300152A (https=)
MX (1) MX2023001385A (https=)
WO (1) WO2022031959A1 (https=)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2024512650A (ja) * 2021-04-02 2024-03-19 エスシーファーマシューティカルズ インコーポレイテッド フロセミドの皮下注入
EP4648761A1 (en) * 2023-01-09 2025-11-19 scPharmaceuticals Inc. Methods of treatment using loop diuretics

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6595961B2 (en) * 2001-04-16 2003-07-22 Becton, Dickinson And Company Sterilizable transfer or storage device for medicaments, drugs and vaccines
PT2981258T (pt) * 2013-04-05 2020-10-19 Scpharmaceuticals Inc Formulações farmacêuticas para administração subcutânea de furosemida
ES3041602T3 (en) * 2018-12-10 2025-11-13 Sq Innovation Ag Pharmaceutical compositions of furosemide and uses thereof

Similar Documents

Publication Publication Date Title
TWI496594B (zh) 噴灑用凝膠型皮膚及/或黏膜附著型製劑及使用該製劑之投藥系統
JP2023002662A5 (https=)
JP2022009125A5 (https=)
US7459430B2 (en) Methods of using ziconotide to treat overactive bladder
JP6353577B2 (ja) 組み合わせ組成物
HRP20240485T1 (hr) Pripravci glp-1 i njihova upotreba
JP2018513188A5 (https=)
JP2023536730A5 (https=)
JP2016520653A5 (https=)
JP2006231070A5 (https=)
AU2010200722A1 (en) Methods of treating non-painful bladder disorders using Alpha2Delta subunit calcium channel modulators
MX2015003110A (es) Sistemas de administracion de farmaco y metodos para el tratamiento de la disfuncion miccional de la vejiga y otros trastornos del tracto urinario inferior.
CN102905689A (zh) 包含低剂量纳曲酮的液体鼻喷雾
JP2010526837A5 (https=)
JP2022518900A5 (https=)
JP2020536854A5 (https=)
JP2020510043A5 (https=)
RU2013112890A (ru) Терапевтическое применение 1-[2-(2,4-диметилфенилсульфанил)фенил]пиперазина
ES2307896T3 (es) Uso de la 4-(2-fluorofenil)-6-metil-2-(1-piperazinil) tieno (2,3-d)-pirimidina para el tratamiento de la incontinencia urinaria.
AR112265A1 (es) Antagonista del receptor de angiotensina ii para la prevención o tratamiento de enfermedades sistémicas en gatos
JP2004536847A5 (https=)
KR101896441B1 (ko) 국소투여형의 연하장애 개선용 의약품
CN102740845A (zh) 微生物感染的治疗
ES2668943T3 (es) Composición farmacéutica para tratar eyaculación precoz y método de tratamiento de la eyaculación precoz
JPH03236330A (ja) 炎症治療剤